Learn More
About Orchestra
Orchestra Life Sciences is a technical consultancy. We provide strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare disease. Orchestra offers services instrumental to clients in nuclear medicine, radiation oncology, cell and gene therapies, regenerative medicines, and biotechnology. We work in concert with our clients to provide unparalleled expertise; speeding time to market.
Align
Our team of experts help clients align business strategies, regulatory approaches, engineering processes, and go-to-market plans.
Accelerate
We accelerate projects by streamlining supply chains, facilitating business relationships, and guiding regulatory compliance.
Achieve
We provide the right expertise at the right time to execute challenging projects, enable effective decision-making, and solve complex technical problems to achieve client goals.
Discover
Our Services
Orchestra’s team of consultants provide end-to-end expertise and support to bring commercial therapies to market
Find Out
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Proven track record of successful project execution
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Subject matter experts with more than 100 years of combined experience in novel therapies
Deep market knowledge and intelligence
Strategic relationships with key service providers, vendors, and suppliers
Radiopharmaceutical subject matter experts in nuclear
regulations, radiochemistry, process development, engineering, operations
Cell and gene therapy expertise in FDA regulations, process and analytical development, engineering, automation, and operations
Learn More
OUR CLIENTS
Orchestra serves clients on multiple continents in the disciplines of:
- Cell and Gene Therapy
- Biotechnology
- Radioligand Therapy
- Nuclear Medicine
- Radiation Oncology
- Fusion
Meet Our
Executive Management
Sumit Verma
Co-Founder & Partner
Emilie Pelletier
Co-Founder & CEO
Castor Armesto
Advisor
Meet Our
Our Team
Becky Cooper
Director of Quality Assurance and Compliance
Ernie Banks
Senior Program Manager & OPEX Leader
Strategic Project Director
Sandra Boyd
Senior Quality Director
Clement Cheung
Senior Consultant, Process Chemistry
Dale Simpson
Senior Advisor
Greg Bushman
Senior Consultant, Radiopharmaceutical Manufacturing
Lakeisha Green
Project Manager
Robert Matteoni
Project Manager
Ralph Butler
Senior Advisor
Sterling Marshall
Quality Engineer and Instrumentation
John schmitz
Senior Project Director
Sam Meer
Vice-President Strategy and Supply chain
Michael Blackton
QA Executive
Kim Prefontaine
Executive Administrative Assistant
Timo Henk
Senior Engineer
Cristian Boas
Senior Radiochemist
Eriselda Leka
Quality Engineer
Erin Maniscalco
Junior Designer
Bruna Teixeira
Quality Engineer
Savani Nagarkar
Project Engineer
Jessica Giffey
Vice-President – Radiopharmaceutical programs
Hiten Patel
Director, Manufacturing operations
Nicholas Baldasaro
Project Director
Brian Kirk
Vice President, Construction
Joe Spinelli
Senior Director, Engineering
Keith Thompson
Senior Technical Program Manager
Lovey Bagga
Associate Director, Finance
Michelle Hackmann
Chief of Staff
Stephanie Bladdick
Project Manager
Zach Lewis
Director, Regulatory and Compliance
Be Up To Date
Industry Momentum Returns: What October’s Funding Wave Signals for the Future
Despite the perceived macroeconomic slowdown, major pharma continues to invest heavily in next-generation gene therapy platforms. Capital is flowing toward programs that show operational growth,
Philadelphia’s Next Chapter: Building the Blueprint for Biotech Growth
Every industry has its inflection point, for biotech, that moment is unfolding in Philadelphia. Anchored by University City’s innovation corridor, Philadelphia has evolved from an

Why CMC Discipline Defines the Future of Advanced Therapies
Author: Zach Lewis, Director, Regulatory and Compliance In today’s race to bring advanced therapies to patients, one hurdle continues to plague the industry: Chemistry, Manufacturing,
Orchestra Life Sciences Relocates Global Headquarters to Philadelphia’s Navy Yard
Relocation reflects Orchestra’s commitment to innovation, ecosystem growth, and building the advancedtherapy workforce of the future Philadelphia, PA, October 22, 2025 — Orchestra Life Sciences

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell TherapyFacility Development
Princeton, NJ, January 14– BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS),

Orchestra Life Sciences Partners with Life Couriers to Expand Supply Chain Capabilities and Broaden Access to Critical Cancer Treatments
Collaboration aims to enhance logistics solutions for advanced therapies and radiopharmaceuticals, ensuring timely delivery and expanding patient access St. Louis, Missouri — September 18, 2024
Feel Free To